CEACAM5 and sclerosing cholangitis: Here, we therefore aimed to evaluate the diagnostic and prognostic capabilities of CA19-9, CEA, CRP and other routinely measured laboratory parameters in a large cohort of CCA patients undergoing tumor resection at our tertiary referral centre between 2010 and 2016 in comparison to healthy control samples and patients with primary sclerosing cholangitis.